Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Syndrome de lyse tumorale.
Grewal K, Herrity E, Pasic I. Grewal K, et al. Among authors: pasic i. CMAJ. 2023 Jul 24;195(28):E969-E970. doi: 10.1503/cmaj.221433-f. CMAJ. 2023. PMID: 37487612 Free PMC article. French. No abstract available.
Tumour lysis syndrome.
Grewal K, Herrity E, Pasic I. Grewal K, et al. Among authors: pasic i. CMAJ. 2023 Apr 11;195(14):E515. doi: 10.1503/cmaj.221433. CMAJ. 2023. PMID: 37040999 Free PMC article. No abstract available.
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Alfaro Moya T, Mattsson J, Remberger M, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Gerbitz A, Pasic I, Novitzky-Basso I, Michelis FV. Alfaro Moya T, et al. Among authors: pasic i. Eur J Haematol. 2023 Oct;111(4):553-561. doi: 10.1111/ejh.14041. Epub 2023 Jul 18. Eur J Haematol. 2023. PMID: 37461810
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Novitzky-Basso I, Chen C, Chen S, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law A, Al-Shaibani Z, Gerbitz A, Pasic I, Mattsson J, Michelis FV. Novitzky-Basso I, et al. Among authors: pasic i. Eur J Haematol. 2021 Sep;107(3):354-363. doi: 10.1111/ejh.13673. Epub 2021 Jun 14. Eur J Haematol. 2021. PMID: 34076909
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Pang I, Chen P, Trinh GV, Remberger M, Novitzky-Basso I, Gerbitz A, Kim DD, Kumar R, Lam W, Law AD, Lipton JH, Viswabandya A, Pasic I, Mattsson J, Michelis FV. Pang I, et al. Among authors: pasic i. Eur J Haematol. 2024 Feb;112(2):301-309. doi: 10.1111/ejh.14117. Epub 2023 Oct 13. Eur J Haematol. 2024. PMID: 37830403
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation.
Sayyed A, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I. Sayyed A, et al. Among authors: pasic i. Transplant Cell Ther. 2024 May;30(5):520.e1-520.e12. doi: 10.1016/j.jtct.2024.03.004. Epub 2024 Mar 8. Transplant Cell Ther. 2024. PMID: 38462215
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J. Pasic I, et al. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00367-1. doi: 10.1016/j.jtct.2024.04.014. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38648898
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM, Nampoothiri RV, Chen C, Pasic I, Al-Shaibani Z, Lam W, Law AD, Michelis FV, Kim DDH, Gerbitz A, Lipton J, Kumar R, Mattsson J, Viswabandya A. Linn SM, et al. Among authors: pasic i. Hematol Oncol Stem Cell Ther. 2023 Apr 4;16(3):230-237. doi: 10.1016/j.hemonc.2021.09.008. Hematol Oncol Stem Cell Ther. 2023. PMID: 34856195
78 results